Breed · Cavalier King Charles Spaniel

Cavalier King Charles Spaniel Health, Life Stage by Life Stage

Cavaliers are the easiest breed in a house and the hardest in a cardiac referral clinic. A CVT's guide to mitral valve disease, syringomyelia, and the early interventions that add years.

Rachel Howland, CVT (ret.)

Updated Apr 24, 2026 · 10 min read · Edited for Veta

At Angell Animal Medical Center, Cavaliers showed up on the cardiology floor in numbers that didn't match their proportion of the general patient population. The breed has a well-known mitral valve problem, and the dogs who walked in the door were usually well-loved, carefully owned, and five to ten years into a disease process that could have been caught and medicated years earlier. That's the central tension of this breed. Cavaliers aren't the ones whose owners ignore their health. They're the ones whose owners didn't know what to ask for, and when.

If you own a Cavalier King Charles Spaniel, here's the health timeline. I built it from the Merck Veterinary Manual, the American College of Veterinary Internal Medicine consensus statements on MVD, the EPIC study published in the Journal of Veterinary Internal Medicine, Cornell's neurology publications on syringomyelia, and the years I spent on the Angell internal-medicine floor. The breed has a specific medical profile. Managed early, it's a good life.

Where this breed comes from, and what that means

Cavalier King Charles spaniels were developed in the United Kingdom as toy spaniels, descended from companion dogs favored by English nobility. The breed was nearly lost during the early twentieth century and reconstructed from a narrow genetic base in the 1920s, which is why certain inherited conditions concentrate heavily in the population. Heart and neurological conditions are the major consequences.

Lifespan runs 9-14 years. Adult weight sits between 5 and 8 kilograms, roughly 11 to 18 pounds. Energy level is moderate, and the breed is content with thirty to forty-five minutes of daily activity, split between walks and play. Cavaliers are companion-oriented rather than independent, which means they do poorly left alone for long stretches and well in households where someone is home most days.

Puppyhood (0 to 12 months)

Puppy visits cover standard vaccines and basic exam, with careful cardiac auscultation at every visit. Most Cavalier puppies have normal hearts in the first year, which is the point of listening: you want to document a clean baseline. Any murmur flagged at puppy age warrants a cardiology referral and echocardiogram, because some Cavaliers have congenital cardiac defects separate from MVD that benefit from early identification.

Early orthopedic care matters in small breeds. A Cavalier puppy should not be climbing furniture or stairs repeatedly, and growth plates close around nine to twelve months. Gentle varied exercise, multiple short walks, puppy socialization, controlled play, builds the foundation without loading still- developing joints.

Puppy eye exams through a veterinary ophthalmologist catch congenital conditions like retinal dysplasia before they matter. A good breeder has certification records; for rescue Cavaliers or puppies without documented lineage, a baseline exam in the first year is worthwhile.

Young adult (1 to 4 years)

The one-year wellness establishes baseline bloodwork. CBC, chemistry, T4, and urinalysis give comparison data for the next decade. By age three or four, the first cardiology-performed echocardiogram establishes the cardiac baseline. Most three-year-old Cavaliers have unremarkable echocardiograms, which is exactly the result you want documented.

This is also the window where syringomyelia signs sometimes appear, usually between ages two and six. The classic presentation is air-scratching, where the dog scratches at the neck or shoulder without actually touching the skin. Yelping at night, neck pain, or reluctance to jump up suggest the same workup. MRI is the diagnostic, and a veterinary neurologist is the specialist. Cornell's neurology service has well-developed protocols for Cavalier SM.

Dental work becomes important in this window. Cavaliers carry crowded teeth in a small mouth, and tartar accumulates fast. Home brushing two to three times per week with dog-formulated toothpaste, plus annual professional evaluation, keeps the disease burden manageable. Skipped years of dental care usually catch up to Cavaliers by age seven or eight.

Mature (4 to 8 years)

This is when MVD typically progresses from preclinical to clinical in Cavaliers. Annual echocardiogram catches the progression before symptoms. The key measurement is whether the heart has enlarged beyond specific dimensions on echocardiogram, which defines ACVIM stage B2. At stage B2, starting pimobendan significantly delays progression to congestive heart failure, per the EPIC study. Most Cavaliers reach stage B2 somewhere between ages five and nine.

Syringomyelia surveillance continues. Any new neurological sign, persistent head-shaking, a change in gait, reluctance to be touched on the head or neck, gets neurology referral. MRI findings guide medical management, which usually involves gabapentin or similar neuropathic pain medications. Surgical options exist for severe cases but are less common.

Body-condition scoring at every visit. Cavaliers are prone to weight gain, which loads the heart harder than a lean dog's heart and accelerates MVD progression at the margin. Measure the food in actual cups and count the treats.

Senior (8 and up)

At eight or nine, wellness visits move to every six months. Full senior workup covers CBC, chemistry with full liver and kidney markers, T4, urinalysis, blood pressure, ECG, and echocardiogram. For Cavaliers already on cardiac medication, the monitoring cadence is often more frequent, with bloodwork every three to four months and echocardiogram at six-month intervals. Plumb's Veterinary Drug Handbook, the reference most US vets keep on their desk, sets the drug-specific monitoring intervals.

Congestive heart failure, when it develops, usually presents as coughing at rest, exercise intolerance, and increased sleeping respiratory rate. A sleeping respiratory rate over thirty breaths per minute, counted at home, is the earliest signal and worth tracking. Your DVM may ask you to log it weekly for dogs in stage B2. When the rate climbs, the medication adjustment conversation starts.

Kidney function deserves specific attention in the senior Cavalier on long-term cardiac medication. ACE inhibitors and diuretics both interact with renal function, and urinalysis plus creatinine trending over time catches drift early. The Cornell internal-medicine service and IRIS staging resources together guide how aggressively to respond.

Breed-aware screening for Cavaliers

Five screens worth knowing about. Cardiac auscultation at every wellness visit, lifetime. Annual cardiology-performed echocardiogram from age three or four. MRI at any neurological sign consistent with syringomyelia. OFA eye examination at puppy age and annually through adulthood. Urinalysis and sleeping respiratory rate tracking in dogs with documented cardiac disease.

Genetic testing for Cavalier-specific conditions is available through commercial labs, including episodic falling syndrome and dry eye curly coat syndrome mutations. MVD and syringomyelia are polygenic and not reliably predicted by current genetic tests. The echocardiogram and MRI remain the primary assessment tools.

Questions worth asking at each stage

Puppy: are both parents echocardiogram-clear per ACVIM protocol, what's our cardiac auscultation cadence, and have we scheduled puppy ophthalmology. Young adult: when's the first cardiology- performed echocardiogram, what's our plan if SM signs appear, and have we established baseline labs. Mature: have we staged MVD on echocardiogram, are we at B2, and is pimobendan indicated. Senior: how often from here, what's our respiratory-rate monitoring plan, and how are we watching renal function.

Where Cavalier care fits in a bigger plan

Breed is one variable in a longer calculation. The senior pets page applies heavily to Cavaliers because the senior-care arithmetic is dominated by cardiac management. The insurance page is essentially non-optional for this breed given the cost profile. The breed health map is the hub this page lives under. For shorter pieces on MVD and cardiac topics, the Veta Journal runs regular updates.

The claim that does the most work on this page: pimobendan at ACVIM stage B2, started before congestive heart failure, extends Cavalier survival by about fifteen months on average per the EPIC study. That's fifteen months that depend entirely on annual echocardiograms catching the staging transition. The annual cardiology visit is the specific action this page is arguing for.

Questions owners ask about Cavalier King Charles health

What's the biggest health concern in Cavaliers?

Mitral valve disease, called MVD, is the dominant health issue in this breed. MVD is a degenerative condition of the heart's mitral valve that causes regurgitation, eventually progressing to congestive heart failure. Cavaliers develop MVD at rates dramatically higher than the general dog population and typically much younger. The Merck Veterinary Manual and the American College of Veterinary Internal Medicine consensus statements both describe MVD as reaching near-universal prevalence in Cavaliers by age ten. The disease has a long preclinical window, meaning the dog feels fine for years while a murmur is audible, and early intervention with medication when the heart begins to enlarge extends survival meaningfully.

How long do Cavaliers typically live?

Cavaliers commonly live 9 to 14 years, a wide range that reflects how heavily breed-specific diseases shape the distribution. A Cavalier with early-onset MVD who doesn't get appropriate cardiac care may survive only eight or nine years. A Cavalier from an ethically-bred line with delayed MVD onset, good preventive care, and early medication intervention often reaches thirteen or fourteen. The Royal Veterinary College VetCompass data and the AKC Canine Health Foundation cardiac research both support that pattern. Nothing about the Cavalier lifespan is random; it tracks heart disease management closely, which is why the rest of this page concentrates there.

What is syringomyelia and should I worry about it?

Syringomyelia, called SM, is a neurological condition where fluid-filled cavities form in the spinal cord, usually because of a mismatch between skull size and brain size called Chiari-like malformation. Cavaliers are by far the most affected breed. Estimates vary, but the Cornell University College of Veterinary Medicine and multiple neurology cohort studies place clinically significant SM rates between 30 and 70 percent in the breed. Signs at home include scratching at the neck or shoulder without touching the skin (called air-scratching), yelping for no visible reason, head and neck pain, and sometimes difficulty walking. MRI is the diagnostic, and it's not a screening test you'd do blindly; it's done at signs.

When should a Cavalier's heart be first evaluated?

Baseline cardiac auscultation at every wellness visit from puppy age forward, and an annual cardiology-performed examination with echocardiogram starting between ages three and four. A responsible breeder follows the ACVIM breeding protocol, which means both parents were echocardiogram-clear for MVD at or after age five before they were bred. The protocol is documented through the Orthopedic Foundation for Animals cardiac database. For adult Cavaliers, the first echocardiogram establishes a baseline. Any audible murmur warrants echocardiogram at that visit to stage the disease. Staging matters because medication is initiated based on specific echocardiogram criteria (heart chamber enlargement), not on the presence of the murmur alone.

Do all Cavaliers eventually need heart medication?

Most do, yes. The ACVIM consensus protocol uses echocardiogram criteria to stage MVD, with medication typically starting at what's called stage B2, meaning the heart has begun enlarging but the dog isn't yet in heart failure. Pimobendan is the first-line drug at that stage, and the EPIC study published in the Journal of Veterinary Internal Medicine demonstrated that starting pimobendan at stage B2 significantly delays progression to heart failure. Diuretics and ACE inhibitors are added later as disease progresses. Most Cavaliers reach stage B2 somewhere between ages six and ten. The Veta medications hub walks through what these drugs do and how to monitor.

Are Cavaliers good with children and other pets?

Temperamentally, Cavaliers are among the most consistently good family dogs in any breed category. The breed's history as a companion spaniel shows up in exceptional patience with children and usually easy integration with other pets. What Cavalier families plan for isn't temperament. It's the steady medical load in the back half of life. A family with children who will grow up with this dog needs to plan for the dog aging into cardiac care and sometimes neurological care starting well before the children are independent. That's an emotional and financial planning conversation worth having early, not a reason to skip the breed.

What should an adult Cavalier's annual workup include?

Annual wellness from age one, including CBC, chemistry, T4, urinalysis, and careful cardiac auscultation. From age three to four, add an annual cardiology-performed evaluation including echocardiogram. From age five forward, any new cough, exercise intolerance, or change in sleeping breath rate triggers an immediate cardiac workup rather than a wait-and-see. The AAHA canine life-stage guidelines endorse this intensified surveillance for breeds with known cardiac predispositions. For senior Cavaliers, the visit frequency moves to every six months, and blood pressure monitoring becomes routine.

Are Cavaliers prone to eye problems?

Yes, though eyes are a secondary concern behind heart and neurology in this breed. The Orthopedic Foundation for Animals Companion Animal Eye Registry tracks Cavalier-specific incidence of dry eye (keratoconjunctivitis sicca), corneal dystrophy, cataracts, and retinal dysplasia. A baseline ophthalmology exam between ages one and three establishes the reference point, and annual exams through a veterinary ophthalmologist are appropriate for Cavaliers with any family history of eye disease. For most Cavaliers, eye surveillance is part of the wellness visit rather than a separate concern.

Is pet insurance essential for Cavaliers?

For Cavaliers, insurance is closer to essential than in many breeds because the breed's major conditions are predictable, progressive, and expensive over time. A full MVD management course across five to seven years of life, including monitoring echocardiograms and the multi-drug cardiac regimen, runs into the thousands annually. An MRI and syringomyelia workup runs $2,500 to $4,000 per exam, and some dogs need repeat imaging. The North American Pet Health Insurance Association's 2024 breed data places Cavaliers among the top breeds for claim frequency and total paid. A policy with no annual cap, short cardiac and neurology waiting periods, and comprehensive hereditary-condition coverage is the shape. The Veta insurance guide covers the specific carriers that handle these claims well.

When Veta is ready

Breed-aware reminders, the day Veta ships.

Veta is the pet health passport being built to hold Cavalier-specific cardiac staging, respiratory-rate logs, and the short list of cardiology questions worth asking at each visit. One note when iOS is live.

utm_source=organic · utm_medium=seo · utm_campaign=breeds · utm_content=cavalier-king-charles-spaniel · purpose=waitlist

About the author

Rachel Howland, CVT (ret.)

Rachel Howland, CVT (ret.), spent a decade in clinic: seven years in a mixed practice in upstate New York, then three on the internal-medicine floor at Angell Animal Medical Center in Boston. She left practice in 2017 and has written about small-animal health since. She lives in Somerville with Juno, an 11-year-old hound mix managing chronic kidney disease, and Bishop, a Siamese cat.

Rachel is Veta's lead editorial contributor. She does not diagnose or prescribe; she explains what your vet's records are telling you and what questions are fair to ask.

Sources

Merck Veterinary Manual. Myxomatous Mitral Valve Disease in Dogs. merckvetmanual.com.
Boswood, A. et al. (2016). "Effect of pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: The EPIC Study." Journal of Veterinary Internal Medicine. doi.org/10.1111/jvim.14586.
Cornell University College of Veterinary Medicine. Neurology service; syringomyelia in Cavaliers. vet.cornell.edu.
Orthopedic Foundation for Animals. Cavalier King Charles cardiac database. ofa.org.
American Animal Hospital Association. Canine Life Stage Guidelines. aaha.org.
AKC Canine Health Foundation. Canine cardiac research grants. akcchf.org.